Burns J M, Tierney D K, Long G D, Lambert S C, Carr B E
Stanford University Hospital, CA, USA.
Oncol Nurs Forum. 1995 Sep;22(8):1219-24.
PURPOSE/OBJECTIVES: To explain the rationale and process of outpatient critical pathway development for sequential high-dose chemotherapy followed by peripheral blood stem cell transplantation.
Published books and journal articles.
Complex treatment for patients with metastatic breast cancer is shifting to the outpatient area. To make this therapy safe and cost effective, a process for monitoring this type of outpatient care needs to be developed.
Collaboration with a multidisciplinary team is important in ensuring quality of care for complex outpatient treatment protocols. Critical pathway development can serve as a road map for delivering this care.
As team leaders, nurses should oversee the critical pathway development and implementation. Nurses also should maintain their role of patient advocacy through monitoring pathway compliance.
目的/目标：解释序贯大剂量化疗后外周血干细胞移植门诊关键路径的基本原理和制定过程。
已出版的书籍和期刊文章。
转移性乳腺癌患者的复杂治疗正转向门诊领域。为使这种治疗安全且具有成本效益，需要制定一种监测此类门诊护理的流程。
与多学科团队合作对于确保复杂门诊治疗方案的护理质量很重要。关键路径的制定可作为提供此类护理的路线图。
作为团队领导者，护士应监督关键路径的制定和实施。护士还应通过监测路径依从性来维持其患者权益维护者的角色。
